At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.
Medical Affairs Clinical Research Scientist - Director
Organization Overview:
At Lilly, we unite caring with discovery to create medicines that make life better for people around the world, and Lilly Oncology has been delivering life-changing cancer medicines for more than 50 years. Our oncology pipeline is one of the largest in Lilly's history and spans targeted therapies, immunology, radioligand platforms, and cell therapy. The Clinical Research Scientist (CRS) is the scientific engine of Lilly's oncology work — advancing evidence generation strategy, owning scientific content quality, and driving external scientific engagement. This role is designed for scientists who operate at the intersection of deep clinical knowledge, strategic thinking, and execution discipline.
Responsibilities:
The OBU Medical Affairs CRS generates, shapes, and disseminates the science connecting Lilly's oncology assets to the clinical community,
Core Expectations
•Scientific Command: Maintain current, defensible command of the assigned disease area, evidence base, and competitive landscape — credible in any substantive scientific exchange.
•Workstream Ownership: Own assigned workstreams end-to-end — anticipate gaps, resolve ambiguity, and drive deliverables without waiting to be directed.
•Content Integrity: Uphold scientific accuracy, platform alignment, and compliance
•Bias to Action: Operate with urgency — move work forward, surface risk early, and deliver on commitments.
•Collaboration & Influence: Partner across Clinical Development, Medical Affairs, HEOR, External Engagement, Commercial, and field medical, to influence scientific direction without positional authority.
Evidence Generation Strategy & Execution
•Translate clinical care gaps in the assigned therapeutic area into a prioritized evidence generation plan inclusive of external research collaborations, investigator initiated trials/research, and real-world data strategies that drive clinical decision-making and payer access.
•Maintain evidence gap maps and align publication and disclosure plans to asset strategy, evolving HCP and payer needs, and timelines.
•Partner with Clinical Development, HEOR, and Affiliates on post-approval study design, lifecycle planning, and integrated clinical-trial and real-world evidence strategies.
•Drive scientific disclosure inclusive of congress abstracts, manuscripts, and plain language summaries accurately and in compliance with FDA, ICH, and Lilly SOPs.
•Review independent grants and healthcare improvement initiatives in partnership with the Lilly Grants Office and Healthcare Improvement Hub.
Medical Communication & Scientific Content
•Shape and contribute to the Scientific Narrative and own its consistent, current, and approved application across content, training, and engagement throughout the lifecycle
•When applicable, build and deliver cross functional Innovation Readiness (i.e. environment and scientific readiness) solutions to close clinical care gaps
•Develop, review, QC and execute scientific omnichannel content across the full range of Medical Affairs deliverables — publications, advisory board materials, congress presentations, HCP education, field tools, and omnichannel formats (video, infographics, plain language summaries, AI-accessible content) — built for the ecosystem through which modern HCPs engage with oncology science.
•Optimize content for digital accessibility and AI readability, ensuring it is easily discoverable, interpretable, and usable by large language models (LLMs).
•Ensure all content is accurate, compliant, and approved
•Provide scientific input to promotional material review, and support medical information associates on reactive medical information responses — keeping both grounded in the approved platform and compliant with Lilly policies.
•May include global responsibilities as the Strategic Content Lead for the team, which serves as the lead for global medical content strategy, holistic content planning, and global content pull-through across affiliate teams
HCP Engagement
•Build and maintain peer-to-peer relationships with oncology thought leaders, professional societies, and HCP communities relevant to the assigned asset and indication — a network that generates actionable insights and strengthens the credibility of Lilly oncology science.
•Shape the design, execution, and insight integration of scientific advisory boards, advising activities, and congress engagements for assigned workstream(s), translating strategic objectives into substantive scientific exchange.
•Inform and maintain a comprehensive, disease state/therapeutic area global list of the top thought leaders in collaboration with external engagement team members
•Drive strategic engagement with TLs according to this list and in collaboration with external engagement.
•Partner with field medical as a scientific resource — equipping them for substantive HCP exchange and routing field insights back into evidence and communication priorities.
Scientific Intelligence & Therapeutic Landscape
•Maintain deep, current expertise in disease biology, clinical landscape, treatment guidelines, competitive data, and payer/HTA standards for the assigned area, and translate it into implications for evidence and content strategy — including how global HTA bodies (EMA, NICE, HAS, CADTH) shape the evidence needed for access.
•Critically evaluate the literature, competitive trial data, and emerging science with the rigor to represent Lilly's scientific position in substantive external discussion.
Training & Development
•Design and deliver internal scientific training for field medical, commercial, and other functions — a core CRS deliverable building scientific capability and supporting launch readiness.
•Contribute to team learning, planning, and cross-functional exchange; serve as a scientific resource
•Ensure all activities comply with applicable laws, ICH/FDA guidance, Good Clinical Practices, Lilly policies, and the Principles of Medical Research.
•Support IBU and affiliate engagement for late-phase and post-approval assets — data summaries, exchange content, and input into global planning — and the hand-off from development-stage to commercialization MA, as directed by M4 and CRP.
Label Support and Promotional Reviews
•Provide clinical data synthesis, scientific context, and medical input to label changes for assigned assets, working with brand teams, Regulatory, and Legal under CRP and M4 direction.
•Serve as designated medical/scientific reviewer of promotional claims and materials, evaluating materials for scientific accuracy prior to approval
•Verify claims are substantiated by cited primary sources (trial data, approved labeling, peer-reviewed literature); flag any claim that outpaces the evidence
•Confirm fair balance between efficacy and safety information, and consistency with current label language
•Partner with Legal/Regulatory to resolve claim conflicts, proposing defensible alternative language when needed
Basic Requirements:
•Advanced degree (PharmD, PhD, MSN with advanced clinical specialty, DVM) with 5 years directly in medical affairs or oncology clinical development accepted where paired with demonstrated strategic workstream leadership.
•BS degree in health/medical/scientific related field with 7-10 years of experience in clinical trials, drug discovery, or clinical development
Additional Skills/Preferences:
•Previous experience in gynecology/oncology or solid tumor medical affairs preferred-including evidence generation planning, publications strategy, and scientific advisory board design and execution.
•Demonstrated ability to influence scientific direction across a cross-functional team without direct authority.
•Demonstrated track record of independently leading evidence generation strategy, scientific narrative development, or content strategy for a major asset or indication.
•Demonstrated ability to design and deliver scientific content for omnichannel and digital platforms, including formats optimized for modern HCP digital engagement and AI-accessible scientific search.
•Launch experience including medical education deployment, congress strategy, and cross-functional launch readiness execution.
•Proven ability to build and maintain strategic KOL relationships that generate actionable scientific insight for the team.
•Business acumen and ability to hold scientific and commercial priorities in the same strategic conversation.
•Familiarity with Lilly internal systems and processes or equivalent processes at another top-tier pharmaceutical company.
Additional Information:
•Travel: 10–25% domestic and international; varies based on asset lifecycle and congress calendar.
Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form ( https://careers.lilly.com/us/en/workplace-accommodation ) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.
Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.
Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).
Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is
$177,000 - $338,800
Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.
#WeAreLilly